Trial Profile
Efficacy of telbivudine versus entecavir in patients with hepatitis B virus-related compensated cirrhosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary) ; Entecavir
- Indications Hepatitis B; Liver cirrhosis
- Focus Adverse reactions; Therapeutic Use
- 08 Dec 2015 New trial record